Plateau Production Target definition

Plateau Production Target means (a) in the case of an Oil Field, the Net Oil Production Rate, or (b) in the case of a Gas Field, the Net Dry Gas Production Rate to be achieved and sustained for the Plateau Production Period in the relevant approved Development Plan.
Plateau Production Target means the Net Production Rate that is to be achieved and sustained for the Plateau Production Period, as bid and as specified in Article 2.2(a)(ii).
Plateau Production Target is the Net Dry Gas Production Rate that was bid and is to be achieved and sustained for the Plateau Production Period as specified in Article 2.2(c).

Examples of Plateau Production Target in a sentence

  • As seen in Figure 9, when the contractual plateau production target is set to 2.95 million barrels per day instead of the 2.85 million barrels per day that was specified in the Rumaila TSC, the deadweight loss decreases from 1.1% relative to the first-best under “TSC Optimal”, to 0.72% relative to the first-best under “TSC Optimal, Contractual Plateau Production Target = 2.95 million barrels/day”.

  • The Office of the Prosecutor General in situations prescribed by law and in accordance with procedures provided by law: 1.1) shall initiate criminal prosecution; 1.2) shall oversee the legality of preliminary inquires and investigations; 1.3) shall present the case for prosecution in court; 1.4) shall bring actions in court to defend the interests of the state; 1.5) shall appeal the judgments, verdicts and decisions; 1.6) shall oversee the execution of sentences and the legality of other sanctions.

  • The Plateau Production Target, at or to the nearest twenty-five (25) million standard cubic feet of Natural Gas per day above the minimum specified in Section 3 to be delivered to the Transfer Point.For the evaluation of bids, each of the bids will be scored by multiplying the Plateau Production Target (“PPT”) bid less the Initial Production Rate (“IPR”) by an amount equal to one hundred (100) less the Remuneration Fee Bid (“RFB”).

  • A written statement is given from theentity to volunteer showing the details of his voluntary participation.

  • By submitting a proposal, your firm acknowledges and irrevocably submits to the laws of the State of Texas and to thejurisdiction of the court system located in Travis County, Texas.

  • Among them are: AMIC, S.O.S, RENLUV, REJE, S.O.S talibé, Casa Emanuel, Catholic Mission, Plan Guinea-Bissau, Portuguese Inter cooperation and some multilateral agencies, namely WHO, UNICEF and UNFPA.

  • The Plateau Production Target, expressed in Barrel of Crude Oil per day to be delivered, at or to the nearest increment above the minimum, as specified in Section 3.

  • DCCP Staff will appropriately notify all property owners within the District boundary and the City will publish the notice of the hearing in a daily newspaper for five days as required by State Statute.

  • The RFB is payable once this Contract Area achieves a Net Oil Production Rate or Adjusted Net Dry Gas Production Rate equal to twenty-five percent (25%) of the Plateau Production Target agreed upon after with the Regional Oil Company after a commercial discovery.

Related to Plateau Production Target

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.

  • Milk product or "dairy product" means cottage cheese, dry curd cottage cheese, reduced fat cottage cheese, lowfat cottage cheese, cream, light cream, light whipping cream, heavy cream, heavy whipping cream, whipped cream, whipped light cream, sour cream, acidified sour cream, cultured sour cream, half-and-half, sour half-and-half, acidified sour half-and-half, cultured sour half-and-half, reconstituted or recombined milk and milk products, concentrated milk, concentrated milk products, skim milk, lowfat milk, frozen milk concentrate, flavored milk, eggnog, buttermilk, cultured milk, cultured lowfat milk, cultured skim milk, yogurt, lowfat yogurt, nonfat yogurt, acidified milk, acidified lowfat milk, acidified skim milk, low-sodium milk, low-sodium lowfat milk, low-sodium skim milk, lactose-reduced milk, lactose-reduced lowfat milk, lactose-reduced skim milk, aseptically processed and packaged milk, milk products with added safe and suitable microbial organisms, and any other milk product made by the addition or subtraction of milkfat or addition of safe and suitable optional ingredients for protein, vitamin, or mineral fortification. Unless a product is considered a milk product under this subdivision, milk product does not include dietary products, infant formula, ice cream or other desserts, cheese, or butter. Milk products include the following:

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Nicotine product means a product that contains nicotine and is not any of the following:

  • Licensed Compound means [***].

  • Anti-Static Product means a product that is labeled to eliminate, prevent, or inhibit the accumulation of static electricity. “Anti-Static Product” does not include “Electronic Cleaner,” “Floor Polish or Wax,” “Floor Coating,” and products that meet the definition of “Aerosol Coating Product” or “Architectural Coating.”

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Roll-on product means any antiperspirant or deodorant that dispenses active ingredients by rolling a wetted ball or wetted cylinder on the affected area.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Product Category means the applicable category which best describes the product as listed in this Section 94508.

  • Drug Substance means an active ingredient that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient.

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.